Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium polystyrene sulfonate resin is a synthetic, insoluble polymer cation-exchange resin that binds potassium ions in the gastrointestinal tract in exchange for sodium ions, thereby promoting the elimination of excess potassium through the feces. It is primarily used for the treatment of hyperkalemia (elevated blood potassium). It is not a biological macromolecule, receptor, enzyme, transporter, or classical drug target, but a pharmacologically active polymer *drug* that acts through a physicochemical mechanism. Known side effects range from mild gastrointestinal symptoms to rare but serious intestinal necrosis[3][5][7].\n\nClarification: *Sodium polystyrene sulfonate resin* is a therapeutic agent, not a molecular "target" such as a protein, receptor, enzyme, or nucleic acid. Its entry as a "target" is **incorrect**. It is itself a drug/substance, not a biological entity that drugs bind to or modulate[3][4][7].
Potassium binding via cation exchange in GI tract (exchanges sodium for potassium)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium polystyrene sulfonate resin (SPS).